Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02023840
Other study ID # 07.2013.ERYTHRITOL.PROED
Secondary ID
Status Completed
Phase Phase 4
First received December 18, 2013
Last updated September 1, 2016
Start date December 2013
Est. completion date December 2015

Study information

Verified date September 2016
Source Proed
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

Aim of the present study is evaluate the use of erythritol powder with/without the adjunct of local metronidazole in the treatment of periodontal pockets.

20 consecutive adult periodontal patients, requiring cause-related therapy as phase 1 of their treatment plan, and presenting ≥4 sites with probing pocket depth ≥4mm will be enrolled. For each patients four sites will be considered for the study, and two sites will be allocated in the test group and two sites will be allocated in the control group. In the test group, ultrasonic debridement of the pocket will be performed using a piezoceramic ultrasonic device with the a tip connected to the handpiece for 5 minutes/pocket. Then, it will be followed by the subgingival use of erythritol powder 2x5 seconds/pocket. At this time the subgingival delivery of metronidazole gel will be provided. In the control group, the same protocol will be used except for the use of a placebo instead of metronidazole. After instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2 weeks.

At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated: Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL).


Description:

The long term results and benefit of infection control in the treatment of periodontal disease have been well documented. According to a cause-related concept, the disruption of bacterial plaque biofilms can be defined as primary objective for the treatment of periodontitis.

In the past few years, glycine powder air polishing showed positive outcomes in removing subgingival biofilm in periodontal pockets, and subgingivally delivered metronidazole seemed to improve the results of scaling and root-planing alone . Recently, a new prophylactic powder has been developed. The special action of the powder is attributable to the new ingredient Erythritol and the extra-fine grains that measure only 14 microns. The small size results on one hand in a minimal impact per grain on the treated surface and on the other hand in a very dense jet of powder, efficient on biofilm.

Aim of the present study is evaluate the use of erythritol powder with/without the adjunct of local metronidazole in the treatment of periodontal pockets.

MATERIALS & METHODS:

20 consecutive adult periodontal patients, requiring cause-related therapy as phase 1 of their treatment plan, and presenting ≥4 sites with probing pocket depth ≥4mm will be enrolled. For each patients four sites will be considered for the study, and two sites will be allocated in the test group and two sites will be allocated in the control group. In the test group, ultrasonic debridement of the pocket will be performed using a piezoceramic ultrasonic device with the tip connected to the Handpiece Led for 5 minutes/pocket. Then, it will be followed by the subgingival use of erythritol powder applied by the use of Perio-Flow Handpiece with Perio-Flow Nozzle, connected to an airflow unit 2x5 seconds/pocket. At this time the subgingival delivery of metronidazole gel will be provided. In the control group, the same protocol will be used except for the use of a placebo instead of metronidazole. After instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2 weeks.

At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated: Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL).


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adult patients suffering from periodontitis at least 4 sites with probing pocket depth =>4mm

Exclusion Criteria:

- Heavy smokers current pregnant patients history of malignancy Long term steroidal or antibiotic therapy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
metronidazole gel

Procedure:
ultrasonics

erythritol

Drug:
placebo


Locations

Country Name City State
Italy PROED, Institute for Professional Education in Dentistry Torino

Sponsors (1)

Lead Sponsor Collaborator
Proed

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Probing pocket Depth change Using a periodontal calibrated PCP-15 mm probe, the pocket depth will be measured baseline, 6 months No
Primary Bleeding on Probing change Using a periodontal calibrated PCP-15 mm probe, the bleeding on probing will be detected baseline, 6 months No
Primary Clinical Attachment level change Using a periodontal calibrated PCP-15 mm probe, the attachment level will be measured baseline, 6 months No
See also
  Status Clinical Trial Phase
Completed NCT04712630 - Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft N/A
Recruiting NCT03997552 - NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration N/A
Completed NCT05908929 - PRF Therapy for Pocket Reduction N/A
Recruiting NCT05722509 - Evaluation of a New Technique for Periodontal Pocket Reduction in the Extraction of Wisdom Teeth N/A
Completed NCT05631600 - Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study Phase 2/Phase 3
Not yet recruiting NCT03588507 - Clinical and Radiographic Evaluation of PPF With or Without NCHA Bone in Treatment of Intrabony Defects N/A
Recruiting NCT06123000 - Modified Widman Flap vs Fibre Retention Osseous Resective Surgery N/A
Completed NCT06200415 - Glucosamine Sulphate Versus Ginger in Non-Surgical Periodontal Therapy Phase 2
Completed NCT03364751 - Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome N/A
Terminated NCT04639661 - Predictors of Periodontal Outcomes Post-sanative Therapy
Enrolling by invitation NCT05125835 - Periodontal Maintenance and the COVID-19 Pandemic
Not yet recruiting NCT06050863 - Local Delivery of Silk Fibroin and Chlorhexidine Phase 1
Not yet recruiting NCT03909568 - Bone Height and Extractions Study N/A
Completed NCT05162417 - Photodynamic in Periodontal Treatment N/A
Completed NCT05803031 - Efficacy of Locally Delivered Tea Tree Oil Gel as an Adjunct to Non-Surgical Periodontal Management N/A
Recruiting NCT05533528 - Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment N/A
Not yet recruiting NCT06309719 - Hyaluronic Acid and Polynucleotides for Supra-bony Defects N/A
Completed NCT02630173 - Evaluation of Endodontic Status on Periodontal Healing of Concomitant Endodontic Periodontal Lesions N/A
Completed NCT02627326 - Chlorhexidine Intracanal Medicament in Periodontal Healing in Concomitant Endo Perio Lesion With Communication Phase 2
Completed NCT04082949 - Autologous Fibrin Glue Application as an Adjunct to Nonsurgical Periodontal Treatment of Chronic Periodontitis Early Phase 1